Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-12

Clinical Trial Update: Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma [NA]

View source ↗

Summary

Clinical trial update on isotretinoin as treatment for young patients with high-risk neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Neuroblastoma | NA | Status: UNKNOWN